Navigation Links
EntreMed Secures $10 Million Strategic Financing
Date:1/23/2012

es in the pathology of several cancers. ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.  ENMD-2076 is currently in a Phase 2 trial for ovarian cancer, and preclinical and clinical activities are ongoing in assessing the compound's applicability for other forms of cancer.

About EntreMed
EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.  ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.  Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About IDG-Accel Fund
IDG-Accel Fund is a private equity investment fund focused on investment in various sectors and is managed by IDG Capital Partners, a leading investment management team in China with over 18-years of investment experience and industry knowledge.

Forward Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time.  Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operati
'/>"/>

SOURCE EntreMed
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
(Date:5/16/2013)... 2013 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... commercialization of innovative therapies for the treatment of acute and ... , President and CEO, will present a corporate overview at ... Hotel in New York , NY.  The ... a.m. ET/6:30 a.m. PT. The presentation will be ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
... Carefx Corp. , a leading provider of interoperable workflow solutions, ... and further develop the Cleveland Clinic business intelligence (BI) dashboards that are ... , , ... of its BI dashboards currently being used to manage business and clinical ...
... May 18 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ... a leading fully,integrated pharmaceutical company producing over-the-counter drugs in ... results,for the first quarter of 2010. Management is working diligently ... , , First Quarter 2010 Financial Highlights, ...
Cached Medicine Technology:Carefx to Collaborate with the Cleveland Clinic to Commercialize CCF Business Intelligence Solution 2Carefx to Collaborate with the Cleveland Clinic to Commercialize CCF Business Intelligence Solution 3China Sky One Medical Announces First Quarter 2010 Results 2China Sky One Medical Announces First Quarter 2010 Results 3China Sky One Medical Announces First Quarter 2010 Results 4China Sky One Medical Announces First Quarter 2010 Results 5China Sky One Medical Announces First Quarter 2010 Results 6China Sky One Medical Announces First Quarter 2010 Results 7China Sky One Medical Announces First Quarter 2010 Results 8China Sky One Medical Announces First Quarter 2010 Results 9China Sky One Medical Announces First Quarter 2010 Results 10China Sky One Medical Announces First Quarter 2010 Results 11China Sky One Medical Announces First Quarter 2010 Results 12China Sky One Medical Announces First Quarter 2010 Results 13China Sky One Medical Announces First Quarter 2010 Results 14
(Date:5/19/2013)... Boca Raton, FL (PRWEB) May 19, 2013 ... have launched the website YazSideEffects.com in a concerted effort ... effects of the combination birth control drugs Yaz, Yasmin ... website offers a wealth of information on the notorious ... about lawsuits against Bayer Pharmaceuticals. , Yaz, Yasmin ...
(Date:5/18/2013)... Colorado (PRWEB) May 18, 2013 Daily Gossip ... of a new review on their page. John Colston, Daily ... readers to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss ... to sustain that carbs are healthy at a time when ... away from highly caloric products. , The diet is ...
(Date:5/18/2013)... Also known as bariatric surgery ... loss surgery that guarantees patients long-term weight loss. Dr. ... to give readers a brief tutorial on this revolutionary ... at New York City’s Mount Sinai School of Medicine. ... a fellowship in Minimally Invasive Bariatric Surgery. He has ...
(Date:5/18/2013)... (HealthDay News) -- Children who swallow high-powered magnets often ... objects, according to a new study. The researchers, ... Orleans, found that more than 79 percent of children ... or an endoscopic procedure, in which a tube containing ... 21 percent of these cases can be treated through ...
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
Breaking Medicine News(10 mins):Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2
... the condition appear to have longer soft palates, research shows ... the breathing disturbance known as obstructive sleep apnea have soft ... people without the condition, researchers report. , The soft palate ... the mouth. , A team at the Seoul National University ...
... Feb. 20 Misonix, Inc. (Nasdaq: MSON ... technology, which in Europe is used for the ablation ... has entered into a new, three year, exclusive distribution ... based in Kfar Saba, Israel, for the distribution of ...
... clot-busting drug delivered directly to the brain , , FRIDAY, ... used for years to open blocked coronary blood vessels, ... vessels clogged from strokes, according to new research. , ... treatment or prevention as well, a panel of researchers ...
... hemodialysis (which removes large toxins) reduces the risk of ... (CKD), according to a study appearing in the March ... Society Nephrology (JASN). The results suggest that this ... and those with diabetes. , In patients with CKD, ...
... The hospital services department at Northwest Kidney Centers ... for health care staffing services from The Joint ... is the nation,s oldest and largest standards-setting and ... stand-alone dialysis centers, NKC has a 55-member hospital ...
... th , 2009 in London SOUTHFIELD, ... middle market investment banking firm, is pleased to announce ... and formed a partnership with Robin Young to present ... spinal implant and instrumentation companies. The Spine Technology ...
Cached Medicine News:Health News:Anatomy May Help Identify Sleep Apnea 2Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:New Advances May Treat Stroke Faster, Better 2Health News:New Advances May Treat Stroke Faster, Better 3Health News:New Advances May Treat Stroke Faster, Better 4Health News:High-flux hemodialysis prolongs survival in many patients with CKD 2Health News:Northwest Kidney Centers Hospital Services Department Awarded Joint Commission Certification 2Health News:UPDATE: P&M Corporate Finance Announces Partnership with Robin Young to Present the Fifth Annual Spine Technology Summit 2
This high-capacity stand-on scale provides extra sensitivity and support to patients who are unsteady on their feet. Advanced technology compensates for patient movement....
... The 5702 is a heavy-duty, stainless ... for the special needs of bariatric patients. ... handrail assure ease and security. The scale ... weighing, allowing you to weigh a continuous ...
... Endo-PAT2000 is a simple and easy to ... PAT signal is recorded using Itamar Medical's ... is analyzed automatically using proprietary advanced Digital ... within seconds of completing the test. The ...
... synthesized by the parathyroid glands [1,2] ... extracellular calcium concentrations. PTH prevents hypocalcemia ... calcium excretion by the kidney. Following ... is rapidly degraded into 4 fragments: ...
Medicine Products: